雾化吸入抗结核药物强化治疗气管支气管结核痰涂(+)患者23例临床观察

【摘要】 目的观察雾化吸入抗结核药物对气管支气管结核痰涂(+)患者的临床疗效。方法将气管支气管结核痰涂(+)患者45例随机分为2组:实验组23例,给予全身抗结核药物治疗同时雾化吸入抗结核药物(疗程1个月,严重病例可连续2个疗程);对照组22例,给予常规全身抗结核药物治疗。结果实验组较对照组患者临床表现改善更迅速和明显,痰涂(+)转为(-)时间明显提前。结论雾化吸入抗结核药物可降低气管支气管结核痰涂(+)患者的传染性;同时减少住院天数,降低住院总费用,提高治疗效价比。更多还原

【Abstract】 Objective Clinical evaluation on the effects of antitubercular agent atomization inhalation in tracheal bronchial tuberculosis sputum smear (+).Methods Divided patients whose tracheal bronchial tuberculosis sputum smear is (+) into two groups randomly.There are 23 cases in experimental group using antitubercular agent atomization inhalation all over(course of treatment is a month,Continue the other one treatment course in serious patients).There are 22 cases in control group are given regular TB drugs.Results The patients in the experimental group with clinical performance improve more quickly and obvious than control group.Ahead of time obviously when sputum smear from (+) to (-).Conclusion Antitubercular agent atomization inhalation is able to reduce infectivity in tracheal bronchial tuberculosis sputum smear (+) patients.At the same time reduce hospitalization days,improve effect price ratio.更多还原